Immucell ICCC
NASDAQ ICCC
$10.52 +0.07 (+0.67%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immucell (ICCC) Land & Improvements (2015 - 2016)

Updated

Immucell (ICCC) recorded Land & Improvements of $348,827 in Q1 2016, up 4.6% from the prior quarter.

Analysis

Immucell (ICCC) Land & Improvements (2015 - 2016) Analysis & Trends

At the end of FY2015, Immucell reported Land & Improvements of $333,486.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Immucell 95.91 Mn 73.35 Mn 2.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 348,827.00
Dec 31, 2015 333,486.00
API Access

Immucell Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=ICCC&period=max&api_key=YOUR_API_KEY